https://www.selleckchem.com/pr....oducts/incb054329.ht
In this Editorial, we summarize the highlights of these articles and place their findings in the broader context of the NMD research field. © 2020. Published by The Company of Biologists Ltd.Duchenne muscular dystrophy (DMD) is a lethal, X-linked disease that causes severe loss of muscle mass and function in young children. Promising therapies for DMD are being developed, but the long lead times required when using clinical outcome measures are hindering progress. This progress would be facilitated by robust molecular biomarkers in b
Like
Comment
Share
